Notch1 phenotype and clinical stage progression in non-small cell lung cancer

被引：0
|
作者：
Dat Nguyen
Larry Rubinstein
Naoko Takebe
Lucio Miele
Joseph E Tomaszewski
Percy Ivy
James H Doroshow
Sherry X Yang
机构：
[1] National Clinical Target Validation Laboratory,Stanley Scott Cancer Center
[2] Division of Cancer Treatment and Diagnosis,undefined
[3] National Cancer Institute,undefined
[4] National Institutes of Health,undefined
[5] Biometric Research Branch,undefined
[6] Division of Cancer Treatment and Diagnosis,undefined
[7] National Cancer Institute,undefined
[8] National Institutes of Health,undefined
[9] Cancer Therapy Evaluation Program,undefined
[10] Division of Cancer Treatment and Diagnosis,undefined
[11] National Cancer Institute,undefined
[12] National Institutes of Health,undefined
[13] Louisiana State University Health Sciences Center and Louisiana Cancer Research Consortium,undefined
[14] Division of Cancer Treatment and Diagnosis,undefined
[15] National Cancer Institute,undefined
[16] National Institutes of Health,undefined
来源：
Journal of Hematology & Oncology | / 8卷
关键词：
Lung cancer; N1-ICD; Notch1; NSCLC; Stage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Notch signaling and targeted therapy in non-small cell lung cancer
    Sun, Jiajun
    Dong, Meichen
    Xiang, Xin
    Zhang, Shubing
    Wen, Doudou
    CANCER LETTERS, 2024, 585
  • [42] Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer
    Matsuyama, W
    Nakagawa, M
    Wakimoto, J
    Hirotsu, Y
    Kawabata, M
    Osame, M
    HUMAN MUTATION, 2003, 21 (04) : 441 - 443
  • [43] SURVIVAL IN COPD PATIENTS WITH STAGE 1 NON-SMALL CELL LUNG CANCER
    Thiruchelvam, Nirosshan
    Sarda, Yash
    Han, Xiaozhen
    Wang, Xiaofeng
    Mazzone, Peter
    CHEST, 2020, 158 (04) : 1463A - 1463A
  • [44] Patterns of Disease Progression with Durvalumab in Stage III Non-small Cell Lung Cancer (PACIFIC)
    Raben, D.
    Rimner, A.
    Senan, S.
    Broadhurst, H.
    Pellas, T.
    Dennis, P. A.
    Faivre-Finn, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (03): : 683 - 683
  • [45] Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation
    Huang, Dayu
    Wang, Shaohua
    Wang, An
    Chen, Xiaofeng
    Zhang, Huijun
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (09) : 788 - 794
  • [46] Expression of NOTCH 1 and 3 is related to inhibition of metastasis and progression in non-small cell lung carcinomas
    Jung, C.
    Lee, S.
    Shin, O.
    Lee, K.
    Kang, C.
    Ko, Y.
    Choi, J.
    HISTOPATHOLOGY, 2008, 53 : 350 - 350
  • [47] Targeting The Hdac6/hsp90 Axis To Destabilize The Notch1 Receptor In Non-Small Cell Lung Cancer
    Deskin, B.
    Shan, B.
    Lasky, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [48] The Biological-Behavioral Effect Of Neuritin On Non-Small Cell Lung Cancer Vascular Endothelial Cells Via VEGFR And Notch1
    Zhang, Qiao
    Zhang, Juan
    Zhang, Jian
    Aerxiding, Patiguli
    Quhai, Amina
    Chen, Cuncun
    Shan, Li
    ONCOTARGETS AND THERAPY, 2019, 12 : 9747 - 9755
  • [49] Surgical strategy for clinical stage I non-small cell lung cancer in octogenarians
    Aoki, T
    Tsuchida, M
    Watanabe, T
    Hashimoto, T
    Koike, T
    Hirono, T
    Hayashi, JI
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 23 (04) : 446 - 450
  • [50] Clinical and Molecular Predictors of Recurrence in Stage I Non-Small Cell Lung Cancer
    Starnes, Sandra L.
    Pathrose, Peterson
    Wang, Jiang
    Succop, Paul
    Morris, John C.
    Bridges, James
    Kupert, Elena Y.
    Anderson, Marshall
    ANNALS OF THORACIC SURGERY, 2012, 93 (05): : 1606 - 1613
12345